-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Rheumatoid arthritis (RA) patients should rapidly achieve remission, or at least low disease activity, to avoid joint destruction that can lead to severe disability and premature death, according to the "Fit the Right Medicine" initiative
In this meta-analysis, the researchers summarized the incidence of adverse events in the placebo group in 101 such studies, including 17,150 patients in the placebo group and 37,819 in the verum group, according to the Medical Dictionary of Regulatory Activities (MedDRA).
In terms of adverse events, nausea (1.
Taken together, patients should be aware that even with placebo medication, "adverse events" may occur that are not related to the addition of verum medication to background therapy
Original source:
Ratna Shree Sharma, et al.
leave a message here
